Terms: = Prostate cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Prognosis
86 results:
1. HIRA-mediated loading of histone variant H3.3 controls androgen-induced transcription by regulation of AR/brd4 complex assembly at enhancers.
Morozov VM; Riva A; Sarwar S; Kim WJ; Li J; Zhou L; Licht JD; Daaka Y; Ishov AM
Nucleic Acids Res; 2023 Oct; 51(19):10194-10217. PubMed ID: 37638746
[TBL] [Abstract] [Full Text] [Related]
2. Nanotherapeutic Approach to Delivery of Chemo- and Gene Therapy for Organ-Confined and Advanced Castration-Resistant prostate cancer.
Sharma S; Mahajan SD; Chevli K; Schwartz SA; Aalinkeel R
Crit Rev Ther Drug Carrier Syst; 2023; 40(4):69-100. PubMed ID: 37075068
[TBL] [Abstract] [Full Text] [Related]
3. Integrative exploration of the mutual gene signatures and immune microenvironment between benign prostate hyperplasia and castration-resistant prostate cancer.
Wu F; Ning H; Sun Y; Wu H; Lyu J
Aging Male; 2023 Dec; 26(1):2183947. PubMed ID: 36974949
[TBL] [Abstract] [Full Text] [Related]
4. Comparing the outcomes of robotic assisted radical prostatectomy in black and white men: Experience of a high-volume center.
Noël J; Moschovas MC; Sandri M; Jaber AR; Rogers T; Patel V
Int Braz J Urol; 2022; 49(1):123-135. PubMed ID: 36512460
[TBL] [Abstract] [Full Text] [Related]
5. METTL3 preferentially enhances non-m
Wei X; Huo Y; Pi J; Gao Y; Rao S; He M; Wei Q; Song P; Chen Y; Lu D; Song W; Liang J; Xu L; Wang H; Hong G; Guo Y; Si Y; Xu J; Wang X; Ma Y; Yu S; Zou D; Jin J; Wang F; Yu J
Nat Cell Biol; 2022 Aug; 24(8):1278-1290. PubMed ID: 35927451
[TBL] [Abstract] [Full Text] [Related]
6. RNA-based biomarkers for the diagnosis, prognosis, and therapeutic response monitoring of prostate cancer.
Bae J; Yang SH; Kim A; Kim HG
Urol Oncol; 2022 Mar; 40(3):105.e1-105.e10. PubMed ID: 34952790
[TBL] [Abstract] [Full Text] [Related]
7. Adipocyte-derived exosomes may promote breast cancer progression in type 2 diabetes.
Jafari N; Kolla M; Meshulam T; Shafran JS; Qiu Y; Casey AN; Pompa IR; Ennis CS; Mazzeo CS; Rabhi N; Farmer SR; Denis GV
Sci Signal; 2021 Nov; 14(710):eabj2807. PubMed ID: 34813359
[TBL] [Abstract] [Full Text] [Related]
8. LEDGF/p75-mediated chemoresistance of mixed-lineage leukemia involves cell survival pathways and super enhancer activators.
Canella A; Van Belle S; Brouns T; Nigita G; Carlon MS; Christ F; Debyser Z
Cancer Gene Ther; 2022 Feb; 29(2):133-140. PubMed ID: 33795806
[TBL] [Abstract] [Full Text] [Related]
9. Integrin expression in correlation to clinicopathological features and prognosis of prostate cancer: A systematic review and meta-analysis.
Drivalos A; Emmanouil G; Gavriatopoulou M; Terpos E; Sergentanis TN; Psaltopoulou T
Urol Oncol; 2021 Apr; 39(4):221-232. PubMed ID: 33558138
[TBL] [Abstract] [Full Text] [Related]
10. RNA-binding protein DDX3 mediates posttranscriptional regulation of androgen receptor: A mechanism of castration resistance.
Vellky JE; McSweeney ST; Ricke EA; Ricke WA
Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28092-28101. PubMed ID: 33106406
[TBL] [Abstract] [Full Text] [Related]
11. Polymorphisms in androgen metabolism genes with serum testosterone levels and prognosis in androgen-deprivation therapy.
Shiota M; Endo S; Fujimoto N; Tsukahara S; Ushijima M; Kashiwagi E; Takeuchi A; Inokuchi J; Uchiumi T; Eto M
Urol Oncol; 2020 Nov; 38(11):849.e11-849.e18. PubMed ID: 32712140
[TBL] [Abstract] [Full Text] [Related]
12. The expression and functional analysis of the sialyl-T antigen in prostate cancer.
Bai R; Luan X; Zhang Y; Robbe-Masselot C; Brockhausen I; Gao Y
Glycoconj J; 2020 Aug; 37(4):423-433. PubMed ID: 32583304
[TBL] [Abstract] [Full Text] [Related]
13. Microtubule-associated protein tau (MAPT) promotes bicalutamide resistance and is associated with survival in prostate cancer.
Sekino Y; Han X; Babasaki T; Goto K; Inoue S; Hayashi T; Teishima J; Shiota M; Takeshima Y; Yasui W; Matsubara A
Urol Oncol; 2020 Oct; 38(10):795.e1-795.e8. PubMed ID: 32430253
[TBL] [Abstract] [Full Text] [Related]
14. The inflammation-related biomarker CXCR7 independently predicts patient outcome after radical prostatectomy.
Bargão Santos P; Lobo J; Félix A; Silva F; Manso RT; Costa JO; Lourenço B; Sequeira JP; Jerónimo C; Patel HHR; Henrique R
Urol Oncol; 2020 Oct; 38(10):794.e17-794.e27. PubMed ID: 32278731
[TBL] [Abstract] [Full Text] [Related]
15. miR-429 as biomarker for diagnosis, treatment and prognosis of cancers and its potential action mechanisms: A systematic literature review.
Guo CM; Liu SQ; Sun MZ
Neoplasma; 2020 Mar; 67(2):215-228. PubMed ID: 31884798
[TBL] [Abstract] [Full Text] [Related]
16. prostate cancer characteristics and cancer-specific mortality of Native American patients.
Deuker M; Knipper S; Pecoraro A; Palumbo C; Rosiello G; Luzzago S; Tian Z; Saad F; Chun F; Karakiewicz PI
Prostate Cancer Prostatic Dis; 2020 Jun; 23(2):277-285. PubMed ID: 31695139
[TBL] [Abstract] [Full Text] [Related]
17. cancer stem cells in prostate cancer radioresistance.
Tsao T; Beretov J; Ni J; Bai X; Bucci J; Graham P; Li Y
Cancer Lett; 2019 Nov; 465():94-104. PubMed ID: 31493443
[TBL] [Abstract] [Full Text] [Related]
18. Extensive serum cytokine analysis in patients with prostate cancer.
Gong D; Wang Y; Wang Y; Chen X; Chen S; Wang R; Liu L; Duan C; Luo S
Cytokine; 2020 Jan; 125():154810. PubMed ID: 31430659
[TBL] [Abstract] [Full Text] [Related]
19. Genetic polymorphism and carbonic anhydrase 9 expression can predict nodal metastatic prostate cancer risk in patients with prostate-specific antigen levels ≤10 ng/ml at initial biopsy.
Lin CY; Wang SS; Yang CK; Li JR; Chen CS; Hung SC; Chiu KY; Cheng CL; Ou YC; Yang SF
Urol Oncol; 2019 Nov; 37(11):814.e9-814.e16. PubMed ID: 31155437
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of correlation between expression of P53 and Malondialdehyde levels in prostate cancer patients.
Arif M; Rashid A; Majeed A; Qaiser F; Razak S
J Pak Med Assoc; 2018 Sep; 68(9):1373-1377. PubMed ID: 30317268
[TBL] [Abstract] [Full Text] [Related]
[Next]
